Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 97.07B | 90.94B | 91.98B | 98.85B | 107.75B | 100.46B |
Gross Profit | 37.06B | 34.89B | 35.54B | 39.09B | 40.87B | 36.88B |
EBITDA | 764.50M | 1.92B | 2.31B | 3.82B | 6.48B | 2.58B |
Net Income | -707.00M | -477.00M | 108.00M | 905.00M | 3.04B | 336.00M |
Balance Sheet | ||||||
Total Assets | 73.01B | 65.00B | 64.96B | 64.21B | 65.08B | 66.61B |
Cash, Cash Equivalents and Short-Term Investments | 5.50B | 2.96B | 2.93B | 3.51B | 4.57B | 3.81B |
Total Debt | 30.47B | 27.21B | 26.17B | 24.05B | 22.07B | 28.30B |
Total Liabilities | 47.88B | 39.22B | 38.38B | 37.38B | 38.67B | 42.90B |
Stockholders Equity | 25.14B | 25.78B | 26.58B | 26.83B | 26.41B | 23.71B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -583.00M | -2.16B | -2.29B | 7.74B | 2.10B |
Operating Cash Flow | 0.00 | 1.78B | 965.00M | -309.00M | 8.79B | 3.86B |
Investing Cash Flow | 0.00 | -2.12B | -3.20B | -2.02B | -1.23B | -1.35B |
Financing Cash Flow | 0.00 | 165.00M | 1.67B | 1.04B | -6.81B | -1.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥11.46B | 17.28 | 1.09% | 18.54% | -20.77% | ||
66 Neutral | ¥11.43B | 11.99 | 3.74% | 4.17% | 28.46% | ||
65 Neutral | ¥10.60B | 72.48 | 3.00% | 3.46% | ― | ||
63 Neutral | $16.82B | 11.32 | -7.02% | 2.91% | 1.72% | -24.85% | |
62 Neutral | ¥7.92B | 14.83 | 2.48% | 6.11% | 3541.65% | ||
58 Neutral | ¥8.10B | 18.19 | ― | 35.50% | ― | ||
53 Neutral | ¥9.56B | ― | 4.81% | 8.47% | 85.95% |